Investigating extracellular vesicles for various diseases
Official title: Extracellular Vesicle Core
Funded at Rhode Island Hospital · NIH-10874437 · Data updated 2026-11-12
This study is looking at tiny particles called extracellular vesicles to see if they can help track how well treatments are working for diseases like Alzheimer's and leukemia, and it's designed to support researchers and doctors in Rhode Island who are working on these important health issues.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $208,547 |
| NIH project number | 5P30GM145500-02 |
| Project ID | NIH-10874437 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include patients diagnosed with Alzheimer's disease, acute myeloid leukemia, or other conditions related to the study of extracellular vesicles.
✕Less likely to help
Patients with conditions unrelated to the focus areas of extracellular vesicles may not receive any benefit from this research.
What this research studies
This research focuses on the role of extracellular vesicles (EVs) in various diseases, including Alzheimer's and acute myeloid leukemia. The Extracellular Vesicle Core at Rhode Island Hospital provides expertise and resources to support researchers in designing experiments, collecting and analyzing data, and preparing for grant submissions. By collaborating with clinical doctors, the core aims to explore the potential of EVs as non-invasive biomarkers for monitoring disease therapy effectiveness. This initiative enhances collaboration and translational research within the Rhode Island research community.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for tracking disease progression and treatment response in patients.
How similar studies have gone: Previous research has shown promise in using extracellular vesicles as biomarkers, indicating potential success for this approach.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Wen, Sicheng — Rhode Island Hospital
- Study coordinator: Wen, Sicheng
Related research
Other NIH-funded projects on the same topics.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Technology-assisted overdose response tools for Rhode Island communities
A Rhode Island hospital-led project will test easy-to-use, tech-enabled tools (like wall buttons, wearable sensors, and a mobile app) to help detect and respond to overdoses in real-world settings.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Point-of-care test to spot risk of liver scarring from Schistosoma japonicum
This project aims to develop a simple clinic test to find people with S. japonicum infection who are likely to develop worsening liver scarring so they can get treatment earlier.
-
Mobile phone-based screening for anemia in young children in western Kenya
A low-cost, phone-based screening approach helps identify anemia in young children in western Kenya so they can get timely care.
-
Role of lactate transporters in lung scarring
Aims to see if blocking lactate transporters can slow or stop scar-forming cells from thickening the lungs in people with fibrotic lung disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.